NCT03366766 2026-02-20Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung CancerThomas Jefferson UniversityPhase 2 Terminated14 enrolled 16 charts
NCT01822496 2019-08-05Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Terminated59 enrolled 16 charts